The Latest Podcasts
Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry
November 19, 2024
Featuring: Juan Pablo Cappello
While the psychedelic industry is facing intense growing pains, the ketamine industry has been allowed to grow, largely unchecked. How did we get here, and how does the ketamine space…
Subscribe
From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis
It becomes more apparent every day how much isolation and focusing so much on the…
Featured Guest: Geoff Bathje, Ph.D.
How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy
There is a delicate balance between risk and efficacy with any psychedelic intervention, but especially…
Featured Guest: Thomas Feegel
Filter
Why Psychedelic Research is Booming: Current Trends and Hurdles
There is more psychedelic research happening today than ever before, but is anyone collecting it…
Featured Guest: Floris Wolswijk
Ketamine-Assisted Therapy at Work? The Future of Employee Benefits
As the mainstreaming of psychedelics continues, ketamine-assisted therapy at work (well, through one’s employer) is…
Featured Guest: Jessica Tracy
Psychedelics Lately – Massachusetts’ Question 4 and Updates in Psychedelics and Chronic Pain
In this episode, Joe and Kyle finally meet up again for the first episode of…
Featured Guest: Joe Moore & Kyle Buller
Philosophy and Psychedelics: Can Metaphysics Bring Meaning to Non-Ordinary States?
While the science of psychedelics is regularly discussed, the intersection of philosophy and psychedelics isn’t…
Featured Guest: Dr. Peter Sjöstedt-Hughes
The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections
As the spectrum of interest in psychedelics broadens more every day, interdisciplinary connections become more…
Featured Guest: Taylor Andrews Flatt, PMHNP, Victor Pablo Acero, Ph.D., Jackie Tileston, & Michael Baime, MD
What You Need to Know About Massachusetts’ Question 4 and the Natural Psychedelic Substances Act
With the passing of the Natural Psychedelic Substances Act (Question 4), Massachusetts could be the…